The World Bank pledged renewed support to the Institut Pasteur de Côte d’Ivoire during an official visit on October 8, 2026, praising the research center’s critical role in regional biosecurity, epidemiological surveillance, and pandemic preparedness across West and Central Africa.
In Plain English: The Clinical Takeaway
- Biosecurity Infrastructure: The Institut Pasteur de Côte d’Ivoire houses high-security laboratories designed to safely study dangerous pathogens that cause severe infectious diseases.
- Regional Impact: Operating as a reference facility, the institute provides vital diagnostic testing and epidemic monitoring not just for local populations, but for neighboring countries.
- Operational Challenges: World Bank officials noted that reliable electricity remains an essential requirement to maintain the continuous functioning of research equipment and installations.
World Bank Delegation Evaluates Adiopodoumé Research Facilities
Trina Haque, the World Bank’s Regional Director for Human Development for West and Central Africa, led a delegation to the institute’s campus in Adiopodoumé. The visit formed part of a broader evaluation of technical capabilities available across Africa for manufacturing vaccines, producing medicines, and advancing biotechnology. Following the tour, Haque commended the scientific rigor of the institution.
“C’est une grande opportunité pour nous de visiter l’Institut Pasteur de Côte d’Ivoire, un institut de recherche de référence,” Haque stated during the visit, describing the facility as a vital resource for both the host country and the wider region.
The discussions highlighted ambitions to expand high-level laboratory infrastructure and accelerate research targeting infectious pathogens. Alongside these development goals, the World Bank delegation reviewed logistical vulnerabilities, specifically emphasizing that consistent electrical grid stability is mandatory to support the continuous functioning of equipment and research installations.
Advanced Platforms and High-Containment Laboratories
During the site inspection, the delegation toured several specialized technical divisions within the facility. These stops included the Epidemic Virus Department, the Molecular Genetics Platform, and the Biological Resource Center, known as CeReB.
The tour also covered the Centre d’étude des pathogènes à risque infectieux sévère, designated as CePRIS, alongside high-security containment laboratories classified at Biosafety Levels 3 and 4, intended for the handling of biological agents presenting high risks.
Professor Méité Syndou, Director General of the institute, welcomed the delegation and outlined the facility’s ongoing contributions to pathogen detection, epidemic tracking, and emergency health responses throughout neighboring states.
Future Strategic Collaboration in West Africa
The October visit underscored a shared commitment between the World Bank and the research center to fortify regional health systems against future biological threats. By reinforcing laboratory capacity and diagnostic accuracy, the partnership aims to bridge critical gaps in epidemic readiness across West and Central Africa. The ongoing collaboration focuses on ensuring that scientific infrastructure can rapidly scale testing, characterization, and intervention measures when novel pathogens emerge.
